Uppsala Reports editor
@UMCGlobalSafety
This year, #MedSafetyWeek takes place from 6–12 November, with the theme “Who can report?” In the first of a special two-part episode on pharmacovigilance communication campaigns, Federica Santoro of the Drug Safety Matters podcast speaks to Mitul Jadeja from the Medicines and Healthcare products Regulatory Agency in the UK about under-reporting and how initiatives like #MedSafetyWeek can help draw attention to medicines safety.
Their discussion covers the long-standing problem of under-reporting in pharmacovigilance systems, how regulators can encourage the public to report side-effects, and why reports from both patients and healthcare professionals are necessary for effective pharmacovigilance.
Subscribe by visiting the Drug Safety Matters website or listen to the podcast here:
